France· FR:62267679
HIPPOVENO, comprimé enrobé
A medicinal product containing marron d'inde (extrait de) (sec), registered in France by CESRA ARZNEIMITTEL (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MARRON D'INDE (EXTRAIT DE) (SEC)
- Manufacturer
- CESRA ARZNEIMITTEL (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009300907702 plaquette(s) PVC PVDC aluminium de 20 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b74ee299-1e43-4319-bb42-e693f4883f2f GET /v1/drugs/b74ee299-1e43-4319-bb42-e693f4883f2f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62267679",
"date_amm": "2017-05-02",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "MARRON D'INDE (EXTRAIT DE) (SEC)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé enrobé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about marron d'inde (extrait de) (sec).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.